DeltaStudy successfully completed
In this multicenter study, 434 patients measured with DeltaScan
A large scale validation study for DeltaScan device performance was executed. Patient data was collected from a wide study population of 434 patients. The aim of the study was to investigate the diagnostic performance of the DeltaScan, a CE-certified device to detect acute encephalopathy and delirium using a brief electroencephalography (EEG) recording, separately in patients admitted to an Intensive Care Unit (ICU), and elderly patient admitted to the ward (non-ICU department). The design of the study was a Cross-sectional, multicentre study in 9 hospitals with 31 different departments; nearly 50% of the patients were in the ICU, the better half of the patients were in a variety of wards (e.g. cardiothoracic surgery, geriatric traumatology, geriatrics, internal medicine, etc). The study results show strong performance (>85% overall diagnostic accuracy) of DeltaScan for acute encephalopathy (a.k.a. delirium) in the variety of hospital departments.

DeltaScan® is an EU registered trademark (Certificate Nr 018280613) Version 2.0

Postal Address (for every letter/parcel/package):
Prolira BV, Kruytgebouw, UInc
Winthontlaan 30C
3526 KV Utrecht
The Netherlands
Visiting Address:
Prolira BV, Kruytgebouw
Padualaan 8
3584 CH Utrecht
T
EW
+31 (0)85 060 1656
info@prolira.com
www.prolira.com